Ribavirin 40-mg/mL Suspension
Download in electronic PDF format for $65
Abstract: A formulation for preparing Ribavirin 40-mg/mL Suspension. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.
Related Keywords:
Loyd V. Allen, Jr., PhD, RPh, ribavirin, antiviral agent, formulation, viral infection, virus, acute respiratory syndrome
| Related Articles from IJPC |
Title/Author
(Click for Abstract / Details / Purchase) |
Issue/Page
View/Buy |
Rapid-Dissolve Technology: An Interview With Loyd V. Allen, Jr., PhD, RPh
Allen Loyd V Jr
|
Nov/Dec 2003
Pg. 449-450
|
Ribavirin 40-mg/mL Suspension
Allen Loyd V Jr
|
Jul/Aug 2007
Pg. 334
|
Wetting and/or Solubilizing Agents, Featured Excipient:
Allen Loyd V Jr
|
Jul/Aug 2001
Pg. 310-312
|
Stability of Ribavirin for Inhalation Packaged in Syringes or Glass Vials when Stored Frozen, Refrigerated, and at Room Temperature
Larson Bayli, Bushman Lane R, Casciano Matthew L, Oldland Alan R, Kiser Jennifer J, Kiser Tyree H
|
Nov/Dec 2016
Pg. 521-525
|
Foscarnet Sodium 24-mg/mL Injection
Allen Loyd V Jr
|
Jul/Aug 2012
Pg. 336
|
Topical Cidofovir for Treatment of Resistant Viral Infections
McElhiney Linda F
|
Sep/Oct 2006
Pg. 324-328
|
Human Immunodeficiency Virus and the Acquired Immune Deficiency Syndrome
Mathews Elizabeth
|
Sep/Oct 2000
Pg. 334
|
Stability of Extemporaneous Oral Ribavirin Liquid Preparation
Chan John P, Tong Henry H Y, Chow Alber H L
|
Nov/Dec 2004
Pg. 486-488
|
Aztreonam Injection
Allen Loyd V Jr
|
Jan/Feb 2014
Pg. 60
|
Compounding for the Treatment of COVID-19 and Long COVID, Part 2: Manifestations of Infection, Nomenclature, Transmission, and Treatment
Riepl Mike
|
Mar/Apr 2023
Pg. 98-107
|
